Tizanidine
Product Images NDC 67296-1567

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 67296-1567). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Structure (842f6165 899e 4f0c 98fd 0a619c84edf1 01)

Chemical structure of Tizanidine hydrochloride showing its molecular framework with chlorine, nitrogen, sulfur atoms, and associated bonds.*

FDA Label Image

Figure-1 (842f6165 899e 4f0c 98fd 0a619c84edf1 02)

A line graph showing plasma Tizanidine concentration (ng/mL) over time (hours) from dosing, comparing 4 mg Tizanidine tablets and capsules with and without food. The graph plots four curves representing these different administration conditions, illustrating changes in drug concentration levels within 24 hours after dosing.*

FDA Label Image

Figure 3 (842f6165 899e 4f0c 98fd 0a619c84edf1 03)

A line graph showing improvement in Ashworth Score over time (hours post-dose) comparing 16 mg tizanidine, 8 mg tizanidine, and placebo. The 16 mg dose shows the greatest improvement peaking between 1 and 3 hours, followed by 8 mg, with placebo showing minimal change. Error bars indicate variability at each time point.*

FDA Label Image

Figure 4 (842f6165 899e 4f0c 98fd 0a619c84edf1 04)

A line graph comparing the improvement in Ashworth Score over time between tizanidine (mean dose 28.8 mg) and placebo groups. Data points are shown at three time intervals: end of titration (Study Week 3), end of maintenance (Study Week 7), and endpoint (last observation carried forward). The graph shows greater improvement with tizanidine compared to placebo at each interval, with error bars representing variability.*

FDA Label Image

Logo (842f6165 899e 4f0c 98fd 0a619c84edf1 05)

FDA Label Image

Label (Sdistributi19050911170 0001)

Label for Tizanidine 4 mg tablets showing a quantity of 15 tablets. The label includes the lot number H18040X1 and expiration date 06/20. It is Rx only, manufactured by Unichem Laboratories Ltd, India, and distributed by RedPharm Drug, Inc. A barcode and QR code are also present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.